Peter T. Masiakos

Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness

Paul P. Szotek, Rafael Pieretti‐Vanmarcke, Peter T. Masiakos et al. · Proceedings of the National Academy of Sciences · 2006 · 756 citations · Full text

Medicine, Oncology, Pharmacology +17

A biodegradable and biocompatible gecko-inspired tissue adhesive

Alborz Mahdavi, Lino Ferreira, Cathryn A. Sundback et al. · Proceedings of the National Academy of Sciences · 2008 · 555 citations · Full text

Engineering, Bioengineering, Biomedical Engineering +16

Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS.

Peter T. Masiakos, David T. MacLaughlin, Shyamala Maheswaran et al. · PubMed · 1999 · 122 citations

Medicine, Cancer Biology, Oncology +13

A Highly Tunable Biocompatible and Multifunctional Biodegradable Elastomer

Maria Pereira, Ben Ouyang, Cathryn A. Sundback et al. · Advanced Materials · 2012 · 113 citations · Full text

Natural Sciences, Bioengineering, Materials Science +17

Clinical Clearance of the Cervical Spine in Blunt Trauma Patients Younger Than 3 Years: A Multi-Center Study of the American Association for the Surgery of Trauma

Rafael Pieretti‐Vanmarcke, George C. Velmahos, Michael L. Nance et al. · The Journal of Trauma: Injury, Infection, and Critical Care · 2009 · 111 citations

Medicine, Radiology, Surgery +17